{"nctId":"NCT01165424","briefTitle":"A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)","startDateStruct":{"date":"2010-04"},"conditions":["Rhinitis, Allergic, Perennial"],"count":80,"armGroups":[{"label":"MFNS 50 Î¼g device","type":"EXPERIMENTAL","interventionNames":["Drug: mometasone furoate"]}],"interventions":[{"name":"mometasone furoate","otherNames":["Nasonex"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects having symptoms of perennial allergic rhinitis of moderate to severe degree.\n* Subjects confirmed to be allergic to non-seasonal environmental antigens (e.g., house dust mite antigen).\n* Male or female outpatients aged 3 to 15 years at the time of providing informed consent.\n\nExclusion Criteria:\n\n* Subjects with coexisting tuberculosis or lower respiratory tract infection, or who have an acute upper respiratory tract infection or acute pharyngolaryngitis, etc. judged by the investigator to require treatment at the time of registration\n* Subjects with coexisting infections or systemic mycosis for which there are no effective antibiotics\n* Subjects with repeated epistaxis\n* Subjects with coexisting fungal infection in nasal/sinus cavity\n* Subjects with a history of hypersensitivity to steroids or ingredients of mometasone furoate nasal spray\n* Subjects with severe hepatic, renal, cardiac, hematological disease, diabetes mellitus, hypertension, or other serious coexisting diseases and whose general condition is poor.\n* Subjects allergic to pollen (cedar, Japanese cypress, birch, grasses, mugwort, common ragweed, etc.) for whom the pollen season coincides with the observation period","healthyVolunteers":false,"sex":"ALL","minimumAge":"3 Years","maximumAge":"15 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events and Adverse Drug Reactions","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Total Nasal Symptom Score","description":"Total nasal symptom score was a composite of 4 symptoms (sneezing, rhinorrhea, nasal congestion, and nasal itching). Each symptom was scored on a scale of 0 = none, 1 = mild, 2 = moderate, and 3 = severe for a total score ranging from 0 to 12. A higher score indicates more severe symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.1","spread":"0.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.9","spread":"0.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.4","spread":"0.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.5","spread":"0.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.8","spread":"0.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":80},"commonTop":["Nasopharyngitis","Blood cortisol decreased","Epistaxis","Pyrexia","Pharyngitis"]}}}